Intralesional meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication to systemic therapy from Rio de Janeiro (2000 to 2006).

The American journal of tropical medicine and hygiene 20120801

In vitro susceptibility to antimonials and amphotericin B of Leishmania infantum strains isolated from dogs in a region lacking drug selection pressure.

Veterinary parasitology 20120706

Possible links between sickle cell crisis and pentavalent antimony.

The American journal of tropical medicine and hygiene 20120601

Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice.

International journal of antimicrobial agents 20120401

Synthesis and anti-leishmanial activity of 5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-amines containing N-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl] moieties.

European journal of medicinal chemistry 20120401

Infiltrated leishmaniasis recidivans cutis on the face: a rare clinical presentation.

Tropical doctor 20120401

The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate.

Parasitology research 20120301

Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: a randomized controlled trial.

Military medicine 20120301

Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children.

The Journal of infectious diseases 20120215

Effectiveness of intralesional meglumine antimoniate in the treatment of mucosal leishmaniasis of the Old World.

The Journal of dermatology 20120201

Comparative proteomics study on meglumine antimoniate sensitive and resistant Leishmania tropica isolated from Iranian anthroponotic cutaneous leishmaniasis patients.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 20120201

The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis.

The Journal of antimicrobial chemotherapy 20120101

Disposition of antimony in rhesus monkeys infected with Leishmania braziliensis and treated with meglumine antimoniate.

Journal of toxicology and environmental health. Part A 20120101

Successful treatment of imported mucosal Leishmania infantum leishmaniasis with miltefosine after severe hypokalemia under meglumine antimoniate treatment.

Journal of travel medicine 20120101

Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis.

Trials 20120101

Tongue nodules in canine leishmaniosis--a case report.

Parasites & vectors 20120101

An experimental approach to studying the effectiveness and safety of meglumine antimoniate formulations.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20111201

[Association of post-transplant lymphoproliferative disease and visceral leishmaniasis after kidney transplantation].

Nephrologie & therapeutique 20111101

Treatment of imported New World cutaneous leishmaniasis in Germany.

International journal of dermatology 20111101

Leishmania amazonensis: effects of oral treatment with copaiba oil in mice.

Experimental parasitology 20111001

Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.

International journal of antimicrobial agents 20111001

Cutaneous leishmaniasis with pseudoepitheliomatous hyperplasia simulating squamous cell carcinoma.

The American Journal of dermatopathology 20110801

Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy.

Archives of Iranian medicine 20110701

Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol.

Veterinary journal (London, England : 1997) 20110601

[Bilateral chronic and granulomatous total uveitis following cutaneous leishmaniasis].

Medecine et maladies infectieuses 20110601

Synthesis and antileishmanial activity of novel 5-(5-nitrofuran-2-y1)-1,3,4-thiadiazoles with piperazinyl-linked benzamidine substituents.

European journal of medicinal chemistry 20110601

Detection of Leishmania amastigotes in peripheral blood from four dogs--Short communication.

Acta veterinaria Hungarica 20110601

Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate.

Journal of the European Academy of Dermatology and Venereology : JEADV 20110501

Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis.

The Southeast Asian journal of tropical medicine and public health 20110501

Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults.

The American journal of tropical medicine and hygiene 20110405

Antihelminthic therapy and antimony in cutaneous leishmaniasis: a randomized, double-blind, placebo-controlled trial in patients co-infected with helminths and Leishmania braziliensis.

The American journal of tropical medicine and hygiene 20110405

Unusual form of cutaneous leishmaniasis: erysipeloid form.

European annals of otorhinolaryngology, head and neck diseases 20110401

Immunotherapy with Imiquimod increases the efficacy of Glucantime therapy of Leishmania major infection.

Iranian journal of immunology : IJI 20110301

Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil.

The American journal of tropical medicine and hygiene 20110204

Therapeutic failure in American cutaneous leishmaniasis is associated with gelatinase activity and cytokine expression.

Clinical and experimental immunology 20110201

Risk factors for relapse of visceral leishmaniasis in Georgia.

Tropical medicine & international health : TM & IH 20110201

Leishmania amazonensis META2 protein confers protection against heat shock and oxidative stress.

Experimental parasitology 20110101

[Mucocutaneous leishmaniasis in Morocco, evidence of the parasite's ecological evolution?].

Medecine et maladies infectieuses 20110101

First report of the use of meglumine antimoniate for treatment of canine leishmaniasis in a pregnant dog.

Journal of the American Animal Hospital Association 20110101

Multidetector computed tomography aspects of tracheal mucosal leishmaniasis localization.

Japanese journal of radiology 20110101

Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments.

Parasites & vectors 20110101

American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.

Revista da Sociedade Brasileira de Medicina Tropical 20110101

Advances in the treatment of cutaneous leishmaniasis in the new world in the last ten years: a systematic literature review.

Anais brasileiros de dermatologia 20110101

Potential utility of hyperbaric oxygen therapy and propolis in enhancing the leishmanicidal activity of glucantime.

Revista do Instituto de Medicina Tropical de Sao Paulo 20110101

Serological monitoring of paediatric visceral leishmaniasis By IFA and ELISA methods.

Turkiye parazitolojii dergisi 20110101

A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis.

Anais brasileiros de dermatologia 20110101

Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents.

Experimental parasitology 20101201

New delivery strategies for the old pentavalent antimonial drugs.

Expert opinion on drug delivery 20101201

Anti-leishmanial and anti-trypanosomal activities of 1,4-dihydropyridines: In vitro evaluation and structure-activity relationship study.

Bioorganic & medicinal chemistry 20101115

Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection.

Transactions of the Royal Society of Tropical Medicine and Hygiene 20101101

[Treatment of severe hemophagocytic syndrome associated with visceral leishmaniasis].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20101101

Risk factors associated with dizziness during treatment of mucosal leishmaniasis with meglumine antimoniate: 16-year retrospective study of cases from Rio de Janeiro, Brazil.

The Journal of laryngology and otology 20101001

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis.

Vaccine 20100914

Pediatric visceral leishmaniasis in Albania: a retrospective analysis of 1,210 consecutive hospitalized patients (1995-2009).

PLoS neglected tropical diseases 20100901

Treatment of acute cutaneous leishmaniasis with intralesional injection of meglumine antimoniate: comparison of conventional technique with mesotherapy gun.

International journal of dermatology 20100901

Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis.

The American journal of tropical medicine and hygiene 20100805

Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 20100801

Treatment of visceral leishmaniasis in children in the Central-West Region of Brazil.

Infection 20100801

HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil.

Memorias do Instituto Oswaldo Cruz 20100801

A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis.

The American journal of tropical medicine and hygiene 20100701

Childhood and adult cutaneous leishmaniasis in Tunisia.

International journal of dermatology 20100701

Glucantime fever with parenteral meglumine antimonate in patients of cutaneous leishmaniasis.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20100701

A 48-year-old man with laryngeal mass and vocal cord palsy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100615

Some remarks about the LeishVet directions for the treatment of canine leishmaniasis.

Veterinary parasitology 20100511

[Visceral childhood leishmaniasis: diagnosis and treatment].

Anales de pediatria (Barcelona, Spain : 2003) 20100501

Leishmaniasis recidivans among school children in Bam, South-east Iran, 1994-2006.

International journal of dermatology 20100501

Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.

Vaccine 20100426

Trypanoside, anti-tuberculosis, leishmanicidal, and cytotoxic activities of tetrahydrobenzothienopyrimidines.

Bioorganic & medicinal chemistry 20100415

Novel antileishmanial chalconoids: synthesis and biological activity of 1- or 3-(6-chloro-2H-chromen-3-yl)propen-1-ones.

European journal of medicinal chemistry 20100401

Mucocutaneous leishmaniasis masquerading as Wegener granulomatosis.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20100401

Genotoxic effects of the antileishmanial drug Glucantime.

Archives of toxicology 20100301

Prolonged absorption of antimony(V) by the oral route from non-inclusion meglumine antimoniate-beta-cyclodextrin conjugates.

Biopharmaceutics & drug disposition 20100301

Combination therapy for visceral leishmaniasis.

The Lancet. Infectious diseases 20100301

Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar).

The American journal of tropical medicine and hygiene 20100301

[Visceral leishmaniasis in immunocompetent adult with severe sepsis].

Annales francaises d'anesthesie et de reanimation 20100301

American tegumentary leishmaniasis in older adults: 44 cases treated with an intermittent low-dose antimonial schedule in Rio de Janeiro, Brazil.

Journal of the American Geriatrics Society 20100301

Leishmanicidal activity of racemic +/- 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline.

Natural product communications 20100301

A case with two unusual findings: cutaneous leishmaniasis presenting as panniculitis and pericarditis after antimony therapy.

International journal of dermatology 20100301

Disseminated leishmaniasis caused by Leishmania tropica in HIV-positive patients in the Islamic Republic of Iran.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 20100301

Lupoid leishmaniasis due to Leishmania major with remaining large scars: report of 2 cases.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 20100301

Cutaneous leishmaniasis of the lid: a report of nine cases.

Korean journal of ophthalmology : KJO 20100201

Comparative efficacies of two antimony regimens to treat Leishmania braziliensis-induced cutaneous Leishmaniasis in rhesus macaques (Macaca mulatta).

Antimicrobial agents and chemotherapy 20100101

In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B.

Tropical medicine & international health : TM & IH 20100101

Localized Cutaneous Leishmaniasis due to Leishmania infantum in a Patient Treated with Infliximab.

Dermatology (Basel, Switzerland) 20100101

Visceral leishmaniasis in a renal transplant recipient treated with allopurinol.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20100101

Lupoid cutaneous leishmaniasis: a report of 16 cases.

Indian journal of dermatology, venereology and leprology 20100101

[Side effects of meglumine antimoniate in cutaneous leishmaniasis: 15 cases].

La Tunisie medicale 20100101

[Mortality due to visceral leishmaniasis: clinical and laboratory characteristics].

Revista da Sociedade Brasileira de Medicina Tropical 20100101

[Visceral leishmaniasis: retrospective study on factors associated with lethality].

Revista da Sociedade Brasileira de Medicina Tropical 20100101

Discoid chronic lupus erythematosus at the site of a previously healed cutaneous leishmaniasis: an example of isotopic response.

Dermatologic therapy 20100101

Detection of Leishmania kDNA in human serum samples for the diagnosis of visceral leishmaniasis.

Transactions of the Royal Society of Tropical Medicine and Hygiene 20091201

[Raised tattoos in a human-immunodeficiency-virus-infected patient].

Enfermedades infecciosas y microbiologia clinica 20091201

Antimony containing drug and ECG abnormalities in children with visceral leishmaniasis.

Biological trace element research 20091201

Antimony in plasma and skin of patients with cutaneous leishmaniasis--relationship with side effects after treatment with meglumine antimoniate.

Tropical medicine & international health : TM & IH 20091201

Short report: Contribution of quantitative real-time polymerase chain reaction to follow-up of visceral leishmaniasis patients treated with meglumine antimoniate.

The American journal of tropical medicine and hygiene 20091201

Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys.

Toxicologic pathology 20091001

Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis.

Veterinary dermatology 20091001

Speciation of Sb(III) and Sb(V) in meglumine antimoniate pharmaceutical formulations by PSA using carbon nanotube electrode.

Journal of pharmaceutical and biomedical analysis 20090908

What is your diagnosis? Peritoneal effusion from a dog.

Veterinary clinical pathology 20090901

AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient.

The American journal of tropical medicine and hygiene 20090801

The potential utility of green tea extract as a novel treatment for cutaneous leishmaniasis.

Journal of alternative and complementary medicine (New York, N.Y.) 20090801

The efficacy of thermotherapy to treat cutaneous leishmaniasis in Colombia: a comparative observational study in an operational setting.

Transactions of the Royal Society of Tropical Medicine and Hygiene 20090701

Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis.

Parasitology research 20090701

[Cutaneous leishmaniasis in rheumatoid arthritis].

La Revue de medecine interne 20090701

Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns.

Transactions of the Royal Society of Tropical Medicine and Hygiene 20090701

Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil.

Transactions of the Royal Society of Tropical Medicine and Hygiene 20090701

Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil.

Tropical doctor 20090701

Efficacy of glucantime in the treatment of Old World cutaneous leishmaniasis.

International journal of dermatology 20090701

Leishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug.

Experimental parasitology 20090601

Drug hypersensitivity syndrome induced by meglumine antimoniate.

The American journal of tropical medicine and hygiene 20090601

Effect of meglumine antimoniate on the pancreas during treatment of visceral leishmaniasis in children.

Medical science monitor : international medical journal of experimental and clinical research 20090601

Antileishmaniasis activity of flavonoids from Consolida oliveriana.

Journal of natural products 20090601

Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.

The Journal of parasitology 20090601

Effects of therapy on haemostasis in dogs infected with Leishmania infantum, Ehrlichia canis, or both combined.

The Veterinary record 20090404

Improved synthesis of seven aromatic Baylis-Hillman adducts (BHA): evaluation against Artemia salina Leach. and Leishmania chagasi.

European journal of medicinal chemistry 20090401

Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: synthesis and in vitro biological evaluation.

European journal of medicinal chemistry 20090401

Glibenclamide modulates glucantime activity and disposition in Leishmania major.

Experimental parasitology 20090401

Rhinophymous leishmaniasis: A new variant.

Dermatology online journal 20090315

[Mucosal complication of cutaneous leishmaniasis].

Biomedica : revista del Instituto Nacional de Salud 20090301

[Outbreak of cutaneous leishmaniasis: about 213 cases in the province of Tizi-Ouzou].

Pathologie-biologie 20090201

Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.

The American journal of tropical medicine and hygiene 20090201

[Leishmaniasis: hospital and population-based incidence, and asymptomatic infection. A disease that is still with us].

Enfermedades infecciosas y microbiologia clinica 20090201

Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment.

Journal of clinical laboratory analysis 20090101

Treatment of cutaneous leishmaniasis in travelers 2009.

Journal of travel medicine 20090101

Visceral childhood leishmaniasis in southern Turkey: experience of twenty years.

The Turkish journal of pediatrics 20090101

Two cases of visceral leishmaniasis in Colombia resistant to meglumine antimonial treatment.

Revista do Instituto de Medicina Tropical de Sao Paulo 20090101

Visceral leishmaniasis in 13 pediatric patients in Turkey: treatment experience.

Turkiye parazitolojii dergisi 20090101

Potential utility of indomethacin in enhancing the leishmanicidal activity of glucantime.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 20090101

Localized cutaneous leishmaniasis of the plantar region: a 40-year outcome.

Dermatology online journal 20081215

Childhood cutaneous leishmaniasis: Experience of a Moroccan unit of dermatology.

Dermatology online journal 20081215

Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF-alpha production, but only via TNF-alpha it indirectly increases nitric oxide production by phagocytes of healthy individuals, in vitro.

International immunopharmacology 20081210

Efficacy of pentavalent antimony, amphotericin B, and miltefosine in Leishmania amazonensis-infected macrophages under normoxic and hypoxic conditions.

The Journal of parasitology 20081201

A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.

Journal of vector borne diseases 20081201

Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice.

Journal of vector borne diseases 20081201

[Mucosal leishmaniasis by contiguity with a skin lesion: another case report from Tunisia].

Medecine tropicale : revue du Corps de sante colonial 20081201

Cutaneous leishmaniasis imported from Colombia to Northcentral Venezuela: implications for travel advice.

Travel medicine and infectious disease 20081101

Electrocardiographic changes in patients with cutaneous leishmaniasis treated with systemic glucantime.

Annals of the Academy of Medicine, Singapore 20081101

[Adverse events related to systemic treatment using Glucantime for cutaneous leishmaniasis: a report from Tunisia].

Medecine tropicale : revue du Corps de sante colonial 20081001

The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.

Veterinary journal (London, England : 1997) 20080901

Activity of a hydroxybibenzyl bryophyte constituent against Leishmania spp. and Trypanosoma cruzi: in silico, in vitro and in vivo activity studies.

European journal of medicinal chemistry 20080901

Clinical efficacy of two different drug combinations for the treatment of canine leishmaniasis.

Veterinary research communications 20080901

Extranodal gammadelta-T-cell lymphoma in a dog with leishmaniasis.

Veterinary clinical pathology 20080901

Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran.

The American journal of tropical medicine and hygiene 20080901

Successful treatment of lupoid cutaneous leishmaniasis with glucantime and topical trichloroacetic acid (a case report).

The Korean journal of parasitology 20080901

Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol.

Veterinary journal (London, England : 1997) 20080801

Clinical presentation and renal evaluation of human visceral leishmaniasis (kala-azar): a retrospective study of 57 patients in Brazil.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20080801

Visceral leishmanisis in paediatrics: a study of 367 cases in southwest Iran.

Tropical doctor 20080701

In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis.

Memorias do Instituto Oswaldo Cruz 20080601

In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum.

Parasitology research 20080501

[An atypical presentation of visceral leshmaniasis in an immunocompetent patient].

Medecine et maladies infectieuses 20080501

Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines.

Bioorganic & medicinal chemistry 20080415

[Glucantime reaction with fatal outcome following treatment of cutaneous leishmaniasis].

Annales de dermatologie et de venereologie 20080401

Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis.

Vaccine 20080317

Nodular lymphangitic subcutaneous dissemination after intralesional antimonial treatment for localized cutaneous leishmaniasis.

Clinical and experimental dermatology 20080301

A case of erysipeloid cutaneous leishmaniasis: atypical and unusual clinical variant.

The American journal of tropical medicine and hygiene 20080301

Speciation of antimony (III) and antimony (V) using hydride generation for meglumine antimoniate pharmaceutical formulations quality control.

Memorias do Instituto Oswaldo Cruz 20080301

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

International journal of dermatology 20080201

Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.

The American journal of tropical medicine and hygiene 20080201

Enhanced oral delivery of antimony from meglumine antimoniate/beta-cyclodextrin nanoassemblies.

International journal of pharmaceutics 20080122

Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis.

Journal of ethnopharmacology 20080117

Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.

Toxicology 20080114

Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda.

Annals of tropical medicine and parasitology 20080101

Mutilating lupoid leishmaniasis: twelve years to make the diagnosis!

Dermatology (Basel, Switzerland) 20080101

Anticancer compounds as leishmanicidal drugs: challenges in chemotherapy and future perspectives.

Current medicinal chemistry 20080101

[Sporotrichoid cutaneous leishmaniasis in Tunisia: a clinical and histological study].

Annales de dermatologie et de venereologie 20080101

[Evaluation of the cumulative effect of meglumine antimoniate on the progeny of swiss mice: biologic assay].

Revista da Associacao Medica Brasileira (1992) 20080101

Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.

Acta dermatovenerologica Croatica : ADC 20080101

Failure of both azithromycin and antimony to treat cutaneous leishmaniasis in Manaus, AM, Brazil.

Revista do Instituto de Medicina Tropical de Sao Paulo 20080101

[Epidemiological situation of visceral leishmaniasis on the Island of São Luis, State of Maranhão].

Revista da Sociedade Brasileira de Medicina Tropical 20080101

[Comparative study between oral miltefosine and parenteral N-metil glucamine antimoniate for the treatment of experimental leishmaniasis caused Leishmania (Leishmania) amazonensis].

Revista da Sociedade Brasileira de Medicina Tropical 20080101

[Effect of a hydrophilic formulation of topical paromomycin on cutaneous leishmaniasis among patients with contraindications for treatment with pentavalent antimonials].

Revista da Sociedade Brasileira de Medicina Tropical 20080101

[Clinical and histological study of lupoid cutaneous leishmaniasis (16 cases)].

Presse medicale (Paris, France : 1983) 20071201

Structure-activity relationship of antileishmanials neolignan analogues.

Bioorganic & medicinal chemistry 20071201

[Cardiotoxicity of n-methyl-glucamine antimoniate (Glucantime). A case report].

Medecine et maladies infectieuses 20071201

Short communication: The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004.

Tropical medicine & international health : TM & IH 20071201

Case report: Leishmaniasis of the upper lip.

Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20071101

Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs.

Parasitology research 20071001

A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.

The American journal of tropical medicine and hygiene 20071001

[Demographic, clinical and therapeutic features of adult visceral leishmaniasis at the Rabta hospital in Tunis (tunisia) from 1983 to 2002].

Bulletin de la Societe de pathologie exotique (1990) 20071001

Evaluation of renal and hepatic functions in dogs naturally infected by visceral leishmaniasis submitted to treatment with meglumine antimoniate.

Research in veterinary science 20070801

Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.

International journal of dermatology 20070801

An HIV-positive man with tattoo induration.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070715

Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate.

Clinical and experimental dermatology 20070701

Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran.

Acta tropica 20070701

Dry type leishmanial lymphadenitis presented as two large parotid and cervical masses.

International journal of dermatology 20070701

Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.

The American journal of tropical medicine and hygiene 20070701

Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.

The Journal of infectious diseases 20070615

Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070615

A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.

The Journal of antimicrobial chemotherapy 20070601

Parenteral aminosidine is not effective for Peruvian mucocutaneous leishmaniasis.

The American journal of tropical medicine and hygiene 20070601

Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.

The Journal of parasitology 20070601

A simple duplex-PCR protocol for routine diagnosis and follow up of canine leishmaniasis.

Parassitologia 20070601

Possible cardioprotective effect of angiotensin-converting enzyme inhibitors during treatment of American tegumentary leishmaniasis with meglumine antimoniate.

Acta tropica 20070501

[Symptomatic hypokalemia caused by meglumine antimoniate].

Annales de dermatologie et de venereologie 20070401

Characterization of circulating lymphocyte subpopulations in canine leishmaniasis throughout treatment with antimonials and allopurinol.

Veterinary parasitology 20070331

Miltefosine in cutaneous leishmaniasis.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20070301

Kala-azar control, Uganda.

Emerging infectious diseases 20070301

Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate.

Veterinary parasitology 20070227

Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate.

The Journal of infectious diseases 20070215

Diffuse cutaneous leishmaniasis in an HIV-positive patient in western Africa.

The Australasian journal of dermatology 20070201

Visceral leishmaniasis: bone marrow biopsy findings.

Journal of pediatric hematology/oncology 20070201

[Treatment of visceral leishmaniasis in children].

Medecine tropicale : revue du Corps de sante colonial 20070201

Localization of varicella around cutaneous leishmaniasis.

Indian journal of dermatology, venereology and leprology 20070101

Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis.

BMC complementary and alternative medicine 20070101

[Sporotrichoid cutaneous leishmaniasis].

Actas dermo-sifiliograficas 20070101

Combined effect of the essential oil from Chenopodium ambrosioides and antileishmanial drugs on promastigotes of Leishmania amazonensis.

Revista do Instituto de Medicina Tropical de Sao Paulo 20070101

Evaluation of meglumine antimoniate effects on liver, kidney and pancreas function tests in patients with cutaneous leishmaniasis.

European journal of dermatology : EJD 20070101

The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model.

Revista da Sociedade Brasileira de Medicina Tropical 20070101

Epidemic of cutaneous leishmaniasis: 109 cases in a population of 500.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 20070101

Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission.

Journal of veterinary medicine. A, Physiology, pathology, clinical medicine 20061201

Childhood cutaneous leishmaniasis: report of 117 cases from Iran.

The Korean journal of parasitology 20061201

Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial.

Archives of dermatology 20061201

Mode of action of beta-cyclodextrin as an absorption enhancer of the water-soluble drug meglumine antimoniate.

International journal of pharmaceutics 20061115

[Visceral leishmaniasis with cardiac affectation in an immunocompetent patient].

Medicina clinica 20061007

Refractory cutaneous leishmaniasis in an adolescent: initial manifestation of type 1 diabetes.

The Journal of infection 20061001

Characterization of reactions of antimoniate and meglumine antimoniate with a guanine ribonucleoside at different pH.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 20061001

Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia.

Annals of tropical medicine and parasitology 20061001

Immunologic tests in patients after clinical cure of visceral leishmaniasis.

The American journal of tropical medicine and hygiene 20061001

[Current situation and future of antileishmanial therapy in Colombia].

Biomedica : revista del Instituto Nacional de Salud 20061001

Leishmania (Viannia) braziliensis infection in two Colombian dogs: a note on infectivity for sand flies and response to treatment.

Biomedica : revista del Instituto Nacional de Salud 20061001

Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis.

International journal of dermatology 20060901

Pseudomonas aeruginosa otochondritis complicating localized cutaneous leishmaniasis: prevention of mutilation by early antibiotic therapy.

The American journal of tropical medicine and hygiene 20060801

The therapeutic effect of combined cryotherapy, paramomycin, and intralesional meglumine antimoniate in treating lupoid leishmaniasis and chronic leishmaniasis.

International journal of dermatology 20060801

Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapy.

Transactions of the Royal Society of Tropical Medicine and Hygiene 20060701

Cryotherapy as an adjunct to systemic antimonials for cutaneous leishmaniasis in children.

Journal of the European Academy of Dermatology and Venereology : JEADV 20060701

Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.

International journal of dermatology 20060701

Improved targeting of antimony to the bone marrow of dogs using liposomes of reduced size.

International journal of pharmaceutics 20060606

[Visceral leishmaniasis in an immunocompetent subject, acquired in the Pyrenees region].

Presse medicale (Paris, France : 1983) 20060601

Disseminated cutaneous leishmaniasis: a patient with 749 lesions.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20060601

Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.

The Journal of infectious diseases 20060515

Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.

PLoS medicine 20060501

Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.

International journal of STD & AIDS 20060501

Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance.

Chemico-biological interactions 20060415

Developmental toxicity of meglumine antimoniate and transplacental transfer of antimony in the rat.

Reproductive toxicology (Elmsford, N.Y.) 20060401

[Adverse effects of intralesional Glucantime in the treatment of cutaneous leishmaniosis].

Medecine et maladies infectieuses 20060401

Are there differences in clinical and laboratory parameters between children and adults with American visceral leishmaniasis?

Acta tropica 20060301

Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.

The Korean journal of parasitology 20060301

Psoriasiform cutaneous leishmaniasis.

International journal of dermatology 20060201

Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.

Veterinary parasitology 20060130

Cutaneous lupoid leishmaniasis: a case report.

Cutis 20060101

Chronic zosteriform cutaneous leishmaniasis.

Indian journal of dermatology, venereology and leprology 20060101

Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment.

Revista da Sociedade Brasileira de Medicina Tropical 20060101

[Occurrence of American tegumentary leishmaniasis in the Mato Grosso do Sul State associated to the infection for Leishmania (Leishmania) amazonensis].

Revista da Sociedade Brasileira de Medicina Tropical 20060101

[Factors associated with treatment failure of cutaneous leishmaniasis with meglumine antimoniate].

Revista da Sociedade Brasileira de Medicina Tropical 20060101

Dynamics of Leishmania-specific immunoglobulin isotypes in dogs with clinical leishmaniasis before and after treatment.

Journal of veterinary internal medicine 20060101

[Ultrasound study of parenchymatous organs in visceral leishmaniasis].

Meditsinskaia parazitologiia i parazitarnye bolezni 20060101

Evaluation of rK39 strip test for the diagnosis of visceral leishmaniasis in infants.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 20060101

An alternative antimonial schedule to be used in cutaneous leishmaniasis when high doses of antimony are undesirable.

Revista da Sociedade Brasileira de Medicina Tropical 20060101

Successful therapeutic response of resistant cases of mucocutaneous leishmaniasis to a very low dose of antimony.

Revista da Sociedade Brasileira de Medicina Tropical 20060101

[Emergent outbreak of visceral leishmaniasis in Mato Grosso do Sul State].

Revista da Sociedade Brasileira de Medicina Tropical 20060101

Pharmacokinetic and parasitological evaluation of the bone marrow of dogs with visceral leishmaniasis submitted to multiple dose treatment with liposome-encapsulated meglumine antimoniate.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20051201

Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.

International journal of dermatology 20051201

[The cutaneous leishmaniasis of the face in Gafsa area, Tunisia].

Bulletin de la Societe de pathologie exotique (1990) 20051201

Childhood visceral leishmaniasis in Muzaffarabad, Azad Jammu and Kashmir: frequency and response to treatment in 61 cases.

JPMA. The Journal of the Pakistan Medical Association 20051101

[Functional status of haemostasis system in patients with visceral leishmaniasis].

Georgian medical news 20051101

Pancreatitis associated with N-methyl-glucamine therapy in a dog with leishmaniasis.

Veterinary research communications 20050801

Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.

The Journal of parasitology 20050801

Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050515

Serum antioxidant activities, malondialdehyde and nitric oxide levels in human cutaneous leishmaniasis.

Clinical and experimental dermatology 20050501

[Spontaneous rupture of the spleen in a patient with visceral leishmaniasis].

Enfermedades infecciosas y microbiologia clinica 20050501

Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis.

Acta tropica 20050401

[Slowly progressing skin ulcers following a stay in Costa Rica].

Enfermedades infecciosas y microbiologia clinica 20050401

Short report: efficacy of pentavalent antimony for treatment of colombian cutaneous leishmaniasis.

The American journal of tropical medicine and hygiene 20050401

Granulomatous lesion on a bitch's nipple caused by Leishmania infantum.

The Veterinary record 20050319

Cutaneous leishmaniasis associated with extensive lymphadenopathy during an epidemic in Ceará State, northeast Brazil.

Acta tropica 20050301

Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate.

Annals of tropical medicine and parasitology 20050301

Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.

Acta tropica 20050201

Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.

The American journal of tropical medicine and hygiene 20050201

Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.

Acta tropica 20050101

Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?

International journal of antimicrobial agents 20050101

[Glucantime injection: benefit versus toxicity].

Medecine et maladies infectieuses 20050101

Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.

European journal of dermatology : EJD 20050101

Retrospective study of 151 patients with cutaneous leishmaniasis treated with meglumine antimoniate.

Revista da Sociedade Brasileira de Medicina Tropical 20050101

[American tegumentary leishmaniasis caused by Leishmania (Viannia) braziliensis in military training area of Zona da Mata in Pernambuco].

Revista da Sociedade Brasileira de Medicina Tropical 20050101

[A fatal case of mucocutaneous leishmaniasis after pentavalent antimonial use].

Revista da Sociedade Brasileira de Medicina Tropical 20050101

Symmetrical cutaneous leishmaniasis.

Acta dermato-venereologica 20050101

A 33-year-old male farmer with progressive gingival swelling and bleeding.

Annals of Saudi medicine 20050101

[Antimonial treatments of leishmaniasis].

Revista da Sociedade Brasileira de Medicina Tropical 20050101

The effect of Glucantime on the labeling of blood constituents with technetium-99m.

Acta cirurgica brasileira 20050101

Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis.

BMC infectious diseases 20050101

Synthesis and antileishmanial activity of 3-imidazolylalkylindoles. Part I.

Journal of enzyme inhibition and medicinal chemistry 20041201

[Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application].

Biomedica : revista del Instituto Nacional de Salud 20041201

Management of leishmanial osteolytic lesions in a hypothyroid dog by partial tarsal arthrodesis.

The Veterinary record 20041030

Emergency initiative to reduce leishmaniasis in Afghanistan.

The Lancet. Infectious diseases 20041001

Evaluation of CO laser efficacy in the treatment of cutaneous leishmaniasis.

International journal of dermatology 20041001

Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents.

The Journal of parasitology 20041001

Leishmaniasis of the lip in a patient with Down's syndrome.

Journal of the European Academy of Dermatology and Venereology : JEADV 20040901

Cross-immunity experiments between different species or strains of Leishmania in rhesus macaques (Macaca mulatta).

The American journal of tropical medicine and hygiene 20040901

Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey.

The Journal of parasitology 20040801

Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine.

The Journal of antimicrobial chemotherapy 20040701

Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.

Acta tropica 20040701

[Change in human visceral leishmaniasis treatment in Italy: retrospective study of 630 patients].

Parassitologia 20040601

[Infantile visceral leishmaniasis in the Campania region, Italy: experience from a Paediatric Referral Centre].

Parassitologia 20040601

[Mediterranean visceral leishmaniasis in immunocompetent children. Report of two cases relapsed after specific therapy].

Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20040601

Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.

International journal of dermatology 20040401

Use of meglumine antimoniate in canine leishmaniasis.

The Veterinary record 20040320

[Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases].

Pathologie-biologie 20040301

[Relapse of visceral leishmaniasis in HIV infection. Benefit of amphotericin B].

La Tunisie medicale 20040301

Multiple leg ulcers in a traveler.

Cleveland Clinic journal of medicine 20040201

Acute pancreatitis caused by meglumine antimoniate given for the treatment of visceral leishmaniasis.

Revista da Sociedade Brasileira de Medicina Tropical 20040101

Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis.

Dermatology (Basel, Switzerland) 20040101

Rapid clearance of circulating Leishmania kinetoplast DNA after treatment of visceral leishmaniasis.

Acta tropica 20040101

Visceral leishmaniasis treatment, Italy.

Emerging infectious diseases 20031201

[Visceral leishmaniasis: new drugs].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20031201

Detection of pathogenic bacteria in skin lesions of patients with chiclero's ulcer. Reluctant response to antimonial treatment.

Memorias do Instituto Oswaldo Cruz 20031201

Rare variants of Cutaneous Leishmaniasis: whitlow, paronychia, and sporotrichoid.

International journal of dermatology 20031001

Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.

The Journal of antimicrobial chemotherapy 20030901

Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid.

International journal of dermatology 20030901

Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment.

American journal of veterinary research 20030801

[Liposomal amphotericin B treatment of cutaneous leishmaniasis contracted in Djibouti and resistant to meglumine antimoniate].

Bulletin de la Societe de pathologie exotique (1990) 20030801

Detection of new endemic areas of cutaneous leishmaniasis in Pakistan: a 6-year study.

International journal of dermatology 20030701

Back from the Peace Corps--with skin lesions from South America.

The Journal of family practice 20030701

Efficacy of 8-bromoguanosine against murine cutaneous leishmaniasis induced with Leishmania amazonensis.

Chemotherapy 20030701

The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.

Annals of tropical medicine and parasitology 20030701

Structural and functional analysis of an amplification containing a PGPA gene in a glucantime-resistant Leishmania (Viannia) guyanensis cell line.

Parasitology research 20030601

[Cutaneous leishmaniasis].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20030601

Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.

Fundamental & clinical pharmacology 20030401

American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline.

International journal of dermatology 20030301

Distribution of liposome-encapsulated antimony in dogs.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20030201

Human cutaneous leishmaniasis due to Leishmania infantum in the Sidi Bourouis focus (Northern Tunisia): epidemiological study and isoenzymatic characterization of the parasites.

Acta tropica 20030101

Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate.

Clinical and experimental dermatology 20030101

Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol.

European journal of dermatology : EJD 20030101

Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device.

Dermatology (Basel, Switzerland) 20030101

High frequency of skin reactions in patients with leishmaniasis treated with meglumine antimoniate contaminated with heavy metals: a comparative approach using historical controls.

Memorias do Instituto Oswaldo Cruz 20030101

[Obstructive acute renal failure revealing visceral leishmaniasis in a diabetic patient].

Nephrologie 20030101

Cutaneous leishmaniasis: an overview.

Journal of postgraduate medicine 20030101

[A comparative study between the efficacy of pentamidine isothionate given in three doses for one week and N-methil-glucamine in a dose of 20mgSbV/day for 20 days to treat cutaneous leishmaniasis].

Revista da Sociedade Brasileira de Medicina Tropical 20030101

Post-kala-azar dermal leishmaniasis associated with AIDS.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20021201

Inhibition of parasite protein kinase C by new antileishmanial imidazolidin-2-one compounds.

Journal of enzyme inhibition and medicinal chemistry 20021201

Effects of the glucantime on the kinetic of biodistribution of radiopharmaceuticals in Wistar rats.

Cellular and molecular biology (Noisy-le-Grand, France) 20021101

Expansion of gammadelta T Cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20021001

Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis.

Veterinary immunology and immunopathology 20020906

Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.

International journal of dermatology 20020801

Unusual location of cutaneous leishmaniasis on the hallux in a Brazilian patient.

International journal of dermatology 20020701

Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate.

International journal of dermatology 20020701

Visceral leishmaniasis in paediatrics.

Current opinion in infectious diseases 20020601

[Cutaneous leishmaniasis of the lid].

Journal francais d'ophtalmologie 20020501

Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20020401

[Isolated laringeal leishmaniasis and bone marrow culture (reply)].

Enfermedades infecciosas y microbiologia clinica 20020301

An outbreak of cutaneous leishmaniasis among soldiers in Belém, Pará State, Brazil, caused by Leishmania (Viannia) lindenbergi n. sp. A new leishmanial parasite of man in the Amazon region.

Parasite (Paris, France) 20020301

Pediatric visceral leishmaniasis in Albania.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20020301

PCR detection of specific Leishmania-DNA in patients with periodontal disease.

Pathologica 20020201

Monitoring of total antimony and its species by ICP-MS and on-line ion chromatography in biological samples from patients treated for leishmaniasis.

Analytical and bioanalytical chemistry 20020201

Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial.

International journal of dermatology 20020201

Evaluation of terbinafine treatment in Leishmania chagasi-infected hamsters (Mesocricetus auratus).

Veterinary parasitology 20020128

Visceral leishmaniasis with pericarditis in an HIV-infected patient.

Scandinavian journal of infectious diseases 20020101

Oral leishmaniasis in a HIV-positive patient. Report of a case involving the palate.

Oral diseases 20020101

Leishmaniasis of the prepuce.

Journal of the European Academy of Dermatology and Venereology : JEADV 20020101

In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.

BMC pharmacology 20020101

Leishmaniasis in the genital area.

Revista do Instituto de Medicina Tropical de Sao Paulo 20020101

Leishmaniasis of the lip.

Acta dermato-venereologica 20020101

An intermittent schedule is better than continuous regimen of antimonial therapy for cutaneous leishmaniasis in the municipality of Rio de Janeiro, Brazil.

Revista da Sociedade Brasileira de Medicina Tropical 20020101

The contributions of plasma membrane Na+-Ca2+-exchange and the Ca2+-ATPase to the regulation of cytosolic calcium ([Ca2+]i) in a clonal pituitary cell line (AtT-20) of mouse corticotropes.

Life sciences 20011228

Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20011201

The traditional and conventional medical treatment of cutaneous leishmaniasis in rural Ecuador.

Revista panamericana de salud publica = Pan American journal of public health 20011201

Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.

The American journal of tropical medicine and hygiene 20011101

Cell surface carbohydrates and in vivo infectivity of glucantime-sensitive and resistant Leishmania (Viannia) guyjanensis cell lines.

Parasitology research 20011101

Chemotherapy of cutaneous leishmaniasis: a review.

Medical microbiology and immunology 20011101

Electrocardiographic findings in Ethiopians on pentavalent antimony therapy for visceral leishmaniasis.

East African medical journal 20011101

Inter-current and nosocomial infections among visceral leishmaniasis patients in Ethiopia: an observational study.

Acta tropica 20011022

Flow cytometry, a useful tool for detecting the lethal effect of pentamidine on Leishmania viannia complex promastigote forms.

Pharmacological research 20011001

Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.

The Journal of dermatological treatment 20010901

Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony.

The American journal of tropical medicine and hygiene 20010801

Immunological selection for Leishmania (Viannia) braziliensis antigens.

Annals of tropical medicine and parasitology 20010701

In vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmania infantum strains from humans and dogs in Spain.

Acta tropica 20010525

Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.

Veterinary parasitology 20010419

Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.

The Pediatric infectious disease journal 20010401

[Effect of intralesional treatment with emetine hydrochloride on Leishmania (Viannia) braziliensis in hamsters].

Investigacion clinica 20010301

[Infiltrated cutaneous leishmaniasis and sporotrichosis caused by Leishmania major. First Senegalese case].

Bulletin de la Societe de pathologie exotique (1990) 20010301

Assessment of Leishmania promastigote growth in vitro by means of nucleoside hydrolase activity determination.

Parasitology research 20010201

Visceral leishmaniasis in a Brazilian child infected perinatally with human immunodeficiency virus.

The Pediatric infectious disease journal 20010201

[A 34-year-old man with lingual tumor. Lingual leishmaniasis in a patient with HIV infection].

Revista clinica espanola 20010201

Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment.

Memorias do Instituto Oswaldo Cruz 20010101

[Meglumine antimoniate].

Revista da Sociedade Brasileira de Medicina Tropical 20010101

Dynamics of the antibody response in patients with therapeutic or spontaneous cure of American cutaneous leishmaniasis.

Transactions of the Royal Society of Tropical Medicine and Hygiene 20010101

Embryotoxicity of meglumine antimoniate in the rat.

Reproductive toxicology (Elmsford, N.Y.) 20010101

Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species.

The American journal of tropical medicine and hygiene 20010101

[Epidemic outbreak of tegumentary leishmaniasis in Puerto Esperanza, Misiones, 1998].

Medicina 20010101

[Circumscribed and confluent papular rash in the trunk and hands in a male patient infected with the human immunodeficiency virus].

Enfermedades infecciosas y microbiologia clinica 20010101

[Visceral leishmaniasis associated with human immunodeficiency virus infection].

Enfermedades infecciosas y microbiologia clinica 20010101

Splenic granulomatous lesions in immunocompetent pediatric patients with visceral leishmaniasis.

Scandinavian journal of infectious diseases 20010101

American cutaneous leishmaniasis as a rare imported disease in Europe: a case report favourably treated with antimonial derivatives.

European journal of epidemiology 20010101

American tegumentary leishmaniasis (ATL) in Rio de Janeiro State, Brazil: main clinical and epidemiologic characteristics.

International journal of dermatology 20000701

South American cutaneous leishmaniasis of the eyelids: report of five cases in Rio de Janeiro State, Brazil.

Ophthalmology 20000101

[American cutaneous leishmaniasis in the sugar cane-producing area of Pernambuco, North-East Brazil].

Sante (Montrouge, France) 20000101

Mucosal leishmaniasis ('espundia') responsive to low dose of N-methyl glucamine (Glucantime) in Rio de Janeiro, Brazil.

Revista do Instituto de Medicina Tropical de Sao Paulo 20000101

Meglumine antimoniate, amiodarone and torsades de pointes: a case report.

Resuscitation 19990901

Cutaneous leishmaniasis: evaluation of 3,074 cases in the Cukurova region of Turkey.

The British journal of dermatology 19990201

[Chronic visceral leishmaniasis during chemotherapy for metastatic osteosarcoma].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 19980301

Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration.

Annals of tropical medicine and parasitology 19971201

The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis. A randomized clinical trial.

The Veterinary quarterly 19970301

[Visceral leishmaniasis in children in the province of Florence].

La Pediatria medica e chirurgica : Medical and surgical pediatrics 19970101

Antimony determination in tissues and serum of hamsters infected with Leishmania garnhami and treated with meglumine antimoniate.

Annals of tropical medicine and parasitology 19940201

Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 19940101

Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 19940101

[Visceral leishmaniasis and multiple organ failure].

Enfermedades infecciosas y microbiologia clinica 19931201

Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment.

Annals of tropical medicine and parasitology 19921201

Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.

The American journal of tropical medicine and hygiene 19920701

[Transitory acute kidney insufficiency and insulin-dependent after treatment of kala-azar with pentamidine and N-methylglucamine antimony].

Archives francaises de pediatrie 19910501

Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime.

Transactions of the Royal Society of Tropical Medicine and Hygiene 19900101

Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala.

The American journal of tropical medicine and hygiene 19900101